| Financial Year |
March 31 2023 |
| Monetary Funds |
270,291,028.54 |
| Held-for-trading Financial Assets |
1,150,000.00 |
| Notes Receivable |
15,578,753.19 |
| Accounts Receivable |
1,683,954,573.16 |
| Advances to Suppliers |
93,899,162.79 |
| Other Receivables |
166,690,495.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
22,136,282.14 |
| Dividend Receivable |
-- |
| Inventories |
474,792,777.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,562,096.37 |
| Total Current Assets |
2,755,718,512.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
50,018,391.43 |
| Long-term Equity Investment |
66,390,764.06 |
| Investment Properties |
-- |
| Fixed Assetes |
171,909,330.81 |
| Under-construction Projects |
4,713,050.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,285,254.48 |
| R&D expenses |
326,129.69 |
| Goodwill |
142,413,155.53 |
| Long-Term Deferred and Prepaid Expenses |
29,482,650.59 |
| Deferred Income Tax Assets |
124,925,634.19 |
| Other Non-Current Assets |
54,253,911.01 |
| Sub-Total of Non-Current Assets |
982,349,972.68 |
| Total Assets |
3,738,068,484.78 |
| Short-Term Loans |
663,251,806.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,336,231.05 |
| Accounts Payable |
726,615,823.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,724,563.02 |
| Taxes Payable |
24,010,297.78 |
| Interest Payable |
7,456,285.05 |
| Dividend Payable |
6,215,380.84 |
| Other payables |
95,029,957.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,905,313.86 |
| Other Current Liabilities |
18,108,825.99 |
| Sub-Total of Current Liabilities |
1,636,075,196.13 |
| Long-term Loans |
19,564,733.47 |
| Bonds Payable |
515,103,332.52 |
| Long-Term Accounts Payable |
19,384,931.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
14,432,134.80 |
| Deferred Income Tax Liabilities |
5,682,442.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
610,054,837.31 |
| Total Liabilities |
2,246,130,033.44 |
| Paid-In Capital(Or Share Stock) |
203,517,111.00 |
| Capital Surplus |
833,435,995.90 |
| Surplus Reserve |
45,256,746.24 |
| LESS:Treasury Stock |
187,680,928.83 |
| Undistributed Profits |
396,876,345.58 |
| Minority Stockholder's Interest |
105,195,847.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,386,742,604.16 |
| Owner's Equity（Stockholder's Equity） |
1,491,938,451.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,738,068,484.78 |
